# Optimal designs for phase II/III drug development programs including methods for discounting of phase II results

> Research article (BMC Medical Research Methodology, 2020) · cited 12× · AI/ML

**Wikidata**: [openalex:W3092519617](https://www.wikidata.org/wiki/openalex:W3092519617)  
**Source**: https://4ort.xyz/entity/optimal-designs-for-phase-ii-iii-drug-development-programs-including-methods-for-discounting-of-phase-ii-results